Close Menu


In spite of hold-ups, the Kansas governor won some Republican support to take her seat in the Obama cabinet.

Paired Ends: Mar 24, 2009


Don St. Pierre

Kevin Conroy has been named the new president and CEO of Exact Sciences, while Don St. Pierre is serving as the acting director of FDA's Office of In Vitro Diagnostics, plus more.

CMS plans to review PGx and gene expression tests for coverage, and will consider how "preventive" rules apply to genetic testing.

Updating the HHS Secretary's Advisory Committee on Genetics, Health, and Society regarding New York’s regulatory stance on consumer genomics firms, a health department official said companies that obtain raw data from an analytical testing facility and send a report to an ordering practitioner are considered laboratories.

Included in the $787 billion stimulus package is additional funding for capital instrument purchases and a new $200 million program to tackle new gaps in knowledge, technologies, and research that could provide immediate rewards with the additional money.

The agency's BARDA branch will fund biomarker or bioassay development for post-nuke or 'dirty bomb' radiation exposure.


New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.